(Q50610735)

16 March 2018

title

Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. (English)

1 reference

16 March 2018

0 references

7

1 reference

16 March 2018

Ulrike Blume-Peytavi

10

object named as

Ulrike Blume-Peytavi

1 reference

16 March 2018

author name string

Brice Mahe

1

1 reference

16 March 2018

Annika Vogt

2

1 reference

16 March 2018

Christelle Liard

3

1 reference

16 March 2018

Darragh Duffy

4

1 reference

16 March 2018

Valérie Abadie

5

1 reference

16 March 2018

Olivia Bonduelle

6

1 reference

16 March 2018

Wolfram Sterry

8

1 reference

16 March 2018

Bernard Verrier

9

1 reference

16 March 2018

Behazine Combadiere

11

1 reference

16 March 2018

language of work or name

English

0 references

publication date

4 December 2008

1 reference

16 March 2018

Journal of Investigative Dermatology

published in

1 reference

16 March 2018

volume

129

1 reference

16 March 2018

issue

5

1 reference

16 March 2018

page(s)

1156-1164

1 reference

16 March 2018

https://scigraph.springernature.com/pub.10.1038/jid.2008.356

exact match

0 references

cites work

Antigen distribution drives programmed antitumor CD8 cell migration and determines its efficiency

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

The human hair follicle immune system: cellular composition and immune privilege

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Particle-based vaccines for transcutaneous vaccination

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

CpG DNA in the prevention and treatment of infections

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Immunization via hair follicles by topical application of naked DNA to normal skin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Skin immunization made possible by cholera toxin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Transcutaneous immunization: a human vaccine delivery strategy using a patch

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Single CX3CL1-Ig DNA administration enhances T cell priming in vivo

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Dose sparing with intradermal injection of influenza vaccine

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Investigation of follicular penetration of topically applied substances

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Nanoparticles--an efficient carrier for drug delivery into the hair follicles.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Transfollicular drug delivery

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

The feasibility of targeted selective gene therapy of the hair follicle

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Penetration profile of microspheres in follicular targeting of terminal hair follicles

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Induction of therapeutically relevant cytotoxic T lymphocytes in humans by percutaneous peptide immunization.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.356

7 January 2021

Identifiers

DOI

10.1038/JID.2008.356

1 reference

16 March 2018

PubMed ID

19052565

1 reference

16 March 2018